Selected research
Market Structure
Global Industrial Hemp in Medical Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Industrial Hemp in Medical market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Industrial Hemp in Medical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Industrial Hemp in Medical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Industrial Hemp in Medical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Industrial Hemp in Medical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Industrial Hemp in Medical include Zhejiang CONBA Pharmaceutical, Yunnan Industrial Hemp, Shanghai Shunho New Materials Technology, Kunming Longjin Pharmaceutical, Jinzhou Qiaopai Biotech, HMI Group, Dezhan Healthcare, CHENGZHI and Tilray, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Industrial Hemp in Medical market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Industrial Hemp in Medical and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Industrial Hemp in Medical sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Industrial Hemp in Medical market size, projected growth trends, production technologies, key applications, and end-use industries.
Industrial Hemp in Medical Segment by Company
Zhejiang CONBA Pharmaceutical
Yunnan Industrial Hemp
Shanghai Shunho New Materials Technology
Kunming Longjin Pharmaceutical
Jinzhou Qiaopai Biotech
HMI Group
Dezhan Healthcare
CHENGZHI
Tilray
Isodiol
HempFlax
Botanical Genetics
Boring Hemp
Industrial Hemp in Medical Segment by Type
Cannabinoid Groups
Non-Cannabinoid Groups
Industrial Hemp in Medical Segment by Application
Clinics
Hospitals
Medical Research Centers
Industrial Hemp in Medical Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Industrial Hemp in Medical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Industrial Hemp in Medical and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Industrial Hemp in Medical.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Industrial Hemp in Medical market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Industrial Hemp in Medical manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Industrial Hemp in Medical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Industrial Hemp in Medical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Cannabinoid Groups
- Non-Cannabinoid Groups
Applications
- Clinics
- Hospitals
- Medical Research Centers
Companies covered
- Zhejiang CONBA Pharmaceutical
- Yunnan Industrial Hemp
- Shanghai Shunho New Materials Technology
- Kunming Longjin Pharmaceutical
- Jinzhou Qiaopai Biotech
- HMI Group
- Dezhan Healthcare
- CHENGZHI
- Tilray
- Isodiol
- HempFlax
- Botanical Genetics
- Boring Hemp
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Industrial Hemp in Medical Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Industrial Hemp in Medical Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Industrial Hemp in Medical Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Industrial Hemp in Medical Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Industrial Hemp in Medical Market Dynamics
- 2.1 Industrial Hemp in Medical Industry Trends
- 2.2 Industrial Hemp in Medical Industry Drivers
- 2.3 Industrial Hemp in Medical Industry Opportunities and Challenges
- 2.4 Industrial Hemp in Medical Industry Restraints
3 Industrial Hemp in Medical Market by Manufacturers
- 3.1 Global Industrial Hemp in Medical Revenue by Manufacturers (2021-2026)
- 3.2 Global Industrial Hemp in Medical Sales by Manufacturers (2021-2026)
- 3.3 Global Industrial Hemp in Medical Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Industrial Hemp in Medical Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Industrial Hemp in Medical Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Industrial Hemp in Medical Manufacturers, Product Type & Application
- 3.7 Global Industrial Hemp in Medical Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Industrial Hemp in Medical Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Industrial Hemp in Medical Players Market Share by Revenue in 2025
- 3.8.3 2025 Industrial Hemp in Medical Tier 1, Tier 2, and Tier 3
4 Industrial Hemp in Medical Market by Type
- 4.1 Industrial Hemp in Medical Type Introduction
- 4.1.1 Cannabinoid Groups
- 4.1.2 Non-Cannabinoid Groups
- 4.2 Global Industrial Hemp in Medical Sales by Type
- 4.2.1 Global Industrial Hemp in Medical Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Industrial Hemp in Medical Sales by Type (2021-2032)
- 4.2.3 Global Industrial Hemp in Medical Sales Market Share by Type (2021-2032)
- 4.3 Global Industrial Hemp in Medical Revenue by Type
- 4.3.1 Global Industrial Hemp in Medical Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Industrial Hemp in Medical Revenue by Type (2021-2032)
- 4.3.3 Global Industrial Hemp in Medical Revenue Market Share by Type (2021-2032)
5 Industrial Hemp in Medical Market by Application
- 5.1 Industrial Hemp in Medical Application Introduction
- 5.1.1 Clinics
- 5.1.2 Hospitals
- 5.1.3 Medical Research Centers
- 5.2 Global Industrial Hemp in Medical Sales by Application
- 5.2.1 Global Industrial Hemp in Medical Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Industrial Hemp in Medical Sales by Application (2021-2032)
- 5.2.3 Global Industrial Hemp in Medical Sales Market Share by Application (2021-2032)
- 5.3 Global Industrial Hemp in Medical Revenue by Application
- 5.3.1 Global Industrial Hemp in Medical Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Industrial Hemp in Medical Revenue by Application (2021-2032)
- 5.3.3 Global Industrial Hemp in Medical Revenue Market Share by Application (2021-2032)
6 Global Industrial Hemp in Medical Sales by Region
- 6.1 Global Industrial Hemp in Medical Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Industrial Hemp in Medical Sales by Region (2021-2032)
- 6.2.1 Global Industrial Hemp in Medical Sales by Region (2021-2026)
- 6.2.2 Global Industrial Hemp in Medical Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Industrial Hemp in Medical Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Industrial Hemp in Medical Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Industrial Hemp in Medical Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Industrial Hemp in Medical Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Industrial Hemp in Medical Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Industrial Hemp in Medical Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Industrial Hemp in Medical Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Industrial Hemp in Medical Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Industrial Hemp in Medical Revenue by Region
- 7.1 Global Industrial Hemp in Medical Revenue by Region
- 7.1.1 Global Industrial Hemp in Medical Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Industrial Hemp in Medical Revenue by Region (2021-2026)
- 7.1.3 Global Industrial Hemp in Medical Revenue by Region (2027-2032)
- 7.1.4 Global Industrial Hemp in Medical Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Industrial Hemp in Medical Revenue (2021-2032)
- 7.2.2 North America Industrial Hemp in Medical Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Industrial Hemp in Medical Revenue (2021-2032)
- 7.3.2 Europe Industrial Hemp in Medical Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Industrial Hemp in Medical Revenue (2021-2032)
- 7.4.2 Asia-Pacific Industrial Hemp in Medical Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Industrial Hemp in Medical Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Industrial Hemp in Medical Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Zhejiang CONBA Pharmaceutical
- 8.1.1 Zhejiang CONBA Pharmaceutical Company Information
- 8.1.2 Zhejiang CONBA Pharmaceutical Business Overview
- 8.1.3 Zhejiang CONBA Pharmaceutical Industrial Hemp in Medical Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Zhejiang CONBA Pharmaceutical Industrial Hemp in Medical Product Portfolio
- 8.1.5 Zhejiang CONBA Pharmaceutical Recent Developments
- 8.2 Yunnan Industrial Hemp
- 8.2.1 Yunnan Industrial Hemp Company Information
- 8.2.2 Yunnan Industrial Hemp Business Overview
- 8.2.3 Yunnan Industrial Hemp Industrial Hemp in Medical Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Yunnan Industrial Hemp Industrial Hemp in Medical Product Portfolio
- 8.2.5 Yunnan Industrial Hemp Recent Developments
- 8.3 Shanghai Shunho New Materials Technology
- 8.3.1 Shanghai Shunho New Materials Technology Company Information
- 8.3.2 Shanghai Shunho New Materials Technology Business Overview
- 8.3.3 Shanghai Shunho New Materials Technology Industrial Hemp in Medical Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Shanghai Shunho New Materials Technology Industrial Hemp in Medical Product Portfolio
- 8.3.5 Shanghai Shunho New Materials Technology Recent Developments
- 8.4 Kunming Longjin Pharmaceutical
- 8.4.1 Kunming Longjin Pharmaceutical Company Information
- 8.4.2 Kunming Longjin Pharmaceutical Business Overview
- 8.4.3 Kunming Longjin Pharmaceutical Industrial Hemp in Medical Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Kunming Longjin Pharmaceutical Industrial Hemp in Medical Product Portfolio
- 8.4.5 Kunming Longjin Pharmaceutical Recent Developments
- 8.5 Jinzhou Qiaopai Biotech
- 8.5.1 Jinzhou Qiaopai Biotech Company Information
- 8.5.2 Jinzhou Qiaopai Biotech Business Overview
- 8.5.3 Jinzhou Qiaopai Biotech Industrial Hemp in Medical Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Jinzhou Qiaopai Biotech Industrial Hemp in Medical Product Portfolio
- 8.5.5 Jinzhou Qiaopai Biotech Recent Developments
- 8.6 HMI Group
- 8.6.1 HMI Group Company Information
- 8.6.2 HMI Group Business Overview
- 8.6.3 HMI Group Industrial Hemp in Medical Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 HMI Group Industrial Hemp in Medical Product Portfolio
- 8.6.5 HMI Group Recent Developments
- 8.7 Dezhan Healthcare
- 8.7.1 Dezhan Healthcare Company Information
- 8.7.2 Dezhan Healthcare Business Overview
- 8.7.3 Dezhan Healthcare Industrial Hemp in Medical Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Dezhan Healthcare Industrial Hemp in Medical Product Portfolio
- 8.7.5 Dezhan Healthcare Recent Developments
- 8.8 CHENGZHI
- 8.8.1 CHENGZHI Company Information
- 8.8.2 CHENGZHI Business Overview
- 8.8.3 CHENGZHI Industrial Hemp in Medical Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 CHENGZHI Industrial Hemp in Medical Product Portfolio
- 8.8.5 CHENGZHI Recent Developments
- 8.9 Tilray
- 8.9.1 Tilray Company Information
- 8.9.2 Tilray Business Overview
- 8.9.3 Tilray Industrial Hemp in Medical Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Tilray Industrial Hemp in Medical Product Portfolio
- 8.9.5 Tilray Recent Developments
- 8.10 Isodiol
- 8.10.1 Isodiol Company Information
- 8.10.2 Isodiol Business Overview
- 8.10.3 Isodiol Industrial Hemp in Medical Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Isodiol Industrial Hemp in Medical Product Portfolio
- 8.10.5 Isodiol Recent Developments
- 8.11 HempFlax
- 8.11.1 HempFlax Company Information
- 8.11.2 HempFlax Business Overview
- 8.11.3 HempFlax Industrial Hemp in Medical Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 HempFlax Industrial Hemp in Medical Product Portfolio
- 8.11.5 HempFlax Recent Developments
- 8.12 Botanical Genetics
- 8.12.1 Botanical Genetics Company Information
- 8.12.2 Botanical Genetics Business Overview
- 8.12.3 Botanical Genetics Industrial Hemp in Medical Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Botanical Genetics Industrial Hemp in Medical Product Portfolio
- 8.12.5 Botanical Genetics Recent Developments
- 8.13 Boring Hemp
- 8.13.1 Boring Hemp Company Information
- 8.13.2 Boring Hemp Business Overview
- 8.13.3 Boring Hemp Industrial Hemp in Medical Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Boring Hemp Industrial Hemp in Medical Product Portfolio
- 8.13.5 Boring Hemp Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Industrial Hemp in Medical Value Chain Analysis
- 9.1.1 Industrial Hemp in Medical Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Industrial Hemp in Medical Production Mode & Process
- 9.2 Industrial Hemp in Medical Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Industrial Hemp in Medical Distributors
- 9.2.3 Industrial Hemp in Medical Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst